B E Korba
Overview
Explore the profile of B E Korba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
758
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peek S, Cote P, Jacob J, Toshkov I, Hornbuckle W, Baldwin B, et al.
Hepatology
. 2000 Dec;
33(1):254-66.
PMID: 11124844
L: -FMAU [1-(2-fluoro-5-methyl-beta,L-arabinofuranosyl) uracil] has been shown to be an effective inhibitor of hepatitis B virus (HBV) and duck hepatitis B virus replication in cell culture and duck hepatitis B...
2.
Cote P, Toshkov I, Bellezza C, Ascenzi M, Roneker C, Ann Graham L, et al.
Hepatology
. 2000 Sep;
32(4 Pt 1):807-17.
PMID: 11003627
Acute hepatitis B virus (HBV) infections either resolve or progress to chronicity. Identification of early deviations in host-virus responses associated with these outcomes can further differentiate cause-effect mechanisms that initiate...
3.
Korba B, Cote P, Hornbuckle W, Schinazi R, Gangemi J, Tennant B, et al.
Antivir Ther
. 2000 Sep;
5(2):95-104.
PMID: 10971862
Cell culture studies in our laboratory previously demonstrated synergistic antiviral activity for the combinations of lamivudine and a novel recombinant hybrid human alpha B/D interferon (rHu alpha B/D IFN) against...
4.
Hostetler K, Beadle J, Hornbuckle W, Bellezza C, Tochkov I, Cote P, et al.
Antimicrob Agents Chemother
. 2000 Jun;
44(7):1964-9.
PMID: 10858362
Acyclovir triphosphate is a potent inhibitor of hepatitis B virus DNA polymerase, but acyclovir treatment provides no benefit in patients with hepatitis B virus infection. This is due in part...
5.
Korba B, Schinazi R, Cote P, Tennant B, Gerin J
Antimicrob Agents Chemother
. 2000 May;
44(6):1757-60.
PMID: 10817750
Emtricitabine [(-)FTC] [(-)-beta-2', 3'-dideoxy-5-fluoro-3'-thiacytidine] has been shown to be an effective inhibitor of hepatitis B virus (HBV) in cell culture, with a potency and selectivity that are essentially identical to...
6.
Korba B, Cote P, Hornbuckle W, Tennant B, Gerin J
Hepatology
. 2000 May;
31(5):1165-75.
PMID: 10796894
The woodchuck hepatitis virus (WHV) and its natural host, the Eastern woodchuck (Marmota monax), have been established as a model of hepatitis B virus (HBV)-induced disease. Several published studies have...
7.
Korba B, Cote P, Hornbuckle W, Schinazi R, Gerin J, Tennant B
Antiviral Res
. 2000 Apr;
45(1):19-32.
PMID: 10774587
Cell culture studies in our laboratory and others have previously demonstrated synergistic antiviral activity for combinations of 3TC (lamivudine) and penciclovir against Hepatitis B Virus (HBV) replication and the Duck...
8.
Chu C, Boudinot F, Peek S, Hong J, Choi Y, Korba B, et al.
Antivir Ther
. 2000 Mar;
3(Suppl 3):113-21.
PMID: 10726061
Preclinical aspects of a potent anti-hepatitis B virus (HBV) L-nucleoside, 1-(2-fluoro-5-methyl-beta-L-arabino-furanosyl)uracil (L-FMAU) are described. L-FMAU was prepared from L-ribose derivatives via either L-xylose or L-arabinose. L-FMAU shows potent antiviral activity...
9.
Morrey J, Korba B, Sidwell R
Antivir Ther
. 2000 Mar;
3(Suppl 3):59-68.
PMID: 10726056
Many transgenic mice carrying either portions of the hepatitis B virus (HBV) genome, or the complete genome, have been developed as models because HBV does not infect any other organisms...
10.
Cote P, Korba B, Miller R, Jacob J, Baldwin B, Hornbuckle W, et al.
Hepatology
. 1999 Dec;
31(1):190-200.
PMID: 10613745
Acute hepadnavirus infections either resolve or progress to chronicity. Factors that influence chronicity as an outcome of hepatitis B virus (HBV) infection in humans can be studied experimentally in the...